PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS PATIENTS IN CANADA

Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63265-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)63265-2/fulltext
Title : PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS PATIENTS IN CANADA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63265-2&doi=10.1016/S1098-3015(10)63265-2
First page :
Section Title :
Open access? : No
Section Order : 117
Categories :
Tags :
Regions :
ViH Article Tags :